Title:
HETEROCYCLIC GLP-1 AGONISTS
Document Type and Number:
WIPO Patent Application WO/2023/138684
Kind Code:
A1
Abstract:
It relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.
More Like This:
| WO/2000/038687 | PROTEASE INHIBITORS |
| WO/2019/057123 | POLYCYCLIC COMPOUND ACTING AS IDO INHIBITOR AND/OR IDO-HDAC DUAL INHIBITOR |
| WO/2011/085126 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT |
Inventors:
HUANG WEI (CN)
LEI HUI (CN)
MENG QINGHUA (CN)
WU FAN (CN)
XING WEIQIANG (CN)
ZHANG HAIZHEN (CN)
LEI HUI (CN)
MENG QINGHUA (CN)
WU FAN (CN)
XING WEIQIANG (CN)
ZHANG HAIZHEN (CN)
Application Number:
PCT/CN2023/073389
Publication Date:
July 27, 2023
Filing Date:
January 20, 2023
Export Citation:
Assignee:
GASHERBRUM BIO INC (US)
HUANG WEI (CN)
HUANG WEI (CN)
International Classes:
C07D401/02; A61K31/4184; A61K31/4188; A61K31/4725; A61P3/00; A61P3/10; C07D401/06; C07D401/14
Domestic Patent References:
| WO2022202864A1 | 2022-09-29 | |||
| WO2021018023A1 | 2021-02-04 | |||
| WO2021081207A1 | 2021-04-29 | |||
| WO2019239371A1 | 2019-12-19 | |||
| WO2018056453A1 | 2018-03-29 |
Foreign References:
| CN115594669A | 2023-01-13 |
Attorney, Agent or Firm:
WU , FENG & ZHANG (CN)
Download PDF: